- This event has passed.
Trends and Challenges of Investing in Medtech
January 28 @ 5:30 pm - 8:00 pm
Venture investment in medtech and digital health has recovered since the 2008 financial crisis, but it is still difficult for medtech entrepreneurs to raise money at critical points in the capital continuum – especially moving from Seed to Series A. Traditional VCs and strategic investors are focused on more mature medtech companies. Early stage medtech companies are therefore forced to rely on sources (including angel groups) who may not be as well versed in and may have misconceptions about the medtech field. This session will provide an overview of the top trends in medtech as well as the challenges early stage companies are facing as they move from concept to commercialization. Whether you are new to investing in early stage medtech companies or interested in hearing the latest industry trends, join us for networking and an informative discussion.
Tiffany Wilson – CEO, Global Center for Medical Innovation & T3 Labs
Tiffany has spent over 15 years bringing innovative medical technology from benchtop to bedside. In 2012, she launched the Global Center for Medical Innovation, an Atlanta-based non-profit organization that represents the Southeast’s first medtech innovation center. GCMI brings together key members of the medical device ecosystem, including universities, research centers, clinicians, early-stage companies, industry and investors, with the goal of accelerating the commercialization of new medical technology.
Today, GCMI’s full-time staff of 58 includes design, biomedical engineering, mechanical engineering, project management, machining, quality system management, study directors/principal investigators, program managers, surgeons, veterinarians, vet techs, and support staff. Her team has supported over 150 innovative medical technologies making their way through design, prototype, preclinical testing, and clinical trials to commercialization. GCMI is catalyzing a highly capital efficient method approach to move innovation to products that impact patient outcomes, bringing the critical assets, infrastructure, partnerships, and expertise needed to support entrepreneurs from concept through preclinical testing.
Tiffany joined GCMI from Scientific Intake, where she was VP of Business Development & Strategy. In 2002, she launched ACell as VP of Corporate Strategy & Finance, leading a broad range of initiatives, including regulatory, reimbursement, and the scientific advisory board. A former consultant & investment banker, she brings considerable experience in strategic planning, business development, operations, and financial analysis.
Tiffany serves as Founding Member of Medtech Women @ SEMDA, was Past-President of the Southeast Medical Device Association (SEMDA), and on the Georgia Bio Board of Directors. She is a Member of the National Advisory Council on Innovation and Entrepreneurship (NACIE) at the U.S. Department of Commerce. In 2015 Tiffany received the Georgia Bio Community Award and in 2017 was presented with the Industry Growth Award. She was recognized by Inc. Magazine as one of “17 Inspiring Women to Watch in 2017” and one of Becker Hospital Review’s “110 Women in Medtech to Know in 2017”.
5:30pm – Drinks and hors d’oeuvres
6:00pm – Meeting starts